[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2003, Vol. 1 ›› Issue (3): 184-186.doi: 10.3736/jcim20030311

Previous Articles     Next Articles

Clinical observation of cinobufacini injection used to treat moderate and advanced primary liver cancer

Zhe Chen1, Xiao-feng Zhai1, Yong-hua Su1, Xu-ying Wan1, Jin Li1, Jue-min Xie2, Bo Gao2   

  1. 1. Department of Traditional Chinese Medicine, Changhai Hospital,Second Military Medical University, Shanghai 200433, China
    2. Anhui Jinchan Pharmaceutical Group,Huaibei, Anhui Province 235000, China
  • Received:2003-04-24 Online:2003-09-20 Published:2003-09-20

RichHTML

0

PDF (PC)

99

Cited

77

Like

Objective

To observe the clinical effect of cinobufacini injection in treating moderate and advanced primary liver cancer (PLC).


Methods

One hundred patients with moderate and advanced PLC were randomly divided into cino-treated group (50 patients) and control group (50 patients). The quality of life, tumor size, some changes of laboratory tests, and survival time were observed.


Results

The progressive rate of cino-treated group (18%) was lower than that of the control group (32%). The quality of life of the cino-treated group (80%) was better than that of the control group (72%), but witbout statistical significance. The survival rate of >12 months of the cino-treated group (30%) was higher than that of the control group (18%). The patients' liver function such as serum total bilirubin and ALT decreased obviously in the cino-treated group while increased a lot in the control group. The level of AFP increased after treatment with statistical significance in the control group while there was no statistical significance in the cino-treated group.


Conclusion

Cinobufacini injection can not only inhibit the proliferation of cancer, but also protect liver function, improve quality of life and prolong survival time.

Key words: cinobufacini, therapy, carcinoma, hepatocytes

CLC Number: 

  • R730.52

"

组别 n 改善
例数		 稳定
例数		 恶化
例数		 总有效率（%）
华蟾素治疗组 50 15 25 10 80
一般治疗组 50 13 23 14 72

"

组别 n CR PR NC PD
华蟾素治疗组 50 0 1 40 9
一般治疗组 50 0 0 34 16

"

组别 n WBC（×109） TBIL（μmol/L） ALT（U/L） AFP（μg/L）
华蟾素治疗组 治疗前
治疗后		 50
50		 4.31±0.56
4.64±0.61		 43.5±9.12
32.8±7.91*△ 		77.6±11.52
61.4±10.09*△		 866.4±151.33
891.7±165.47△
一般治疗组 治疗前
治疗后		 50
50		 4.51±0.58
4.32±0.57		 37.4±8.32
54.6±9.97*		 84.2±12.76
101.4±14.37*		 903.7±190.66
1 310.2±211.29*

"

组别 n 3个月 6个月 12个月 >12个月
华蟾素治疗组 50 39 31 17 15
一般治疗组 50 40 29 10 9
[1] 中华人民共和国卫生部医政司. 中国常见恶性肿瘤诊治规范,第二分册:原发性肝癌(第1版)[M]. 北京: 北京医科大学中国协和医科大学联合出版社, 1990,( 第1版):1
[2] 汤钊猷, 余业勤 . 原发性肝癌(第2版)[M]. 上海: 上海科学技术出版社, 1999,( 第2版):271-278
[3] 张振玉, 张昆和, 王崇文 , 等. 华蟾素对三种消化系统肿瘤细胞杀伤机制的研究[J]. 中药药理与临床, 1999,15(5):28-29
doi: 10.3969/j.issn.1001-859X.1999.05.014
[4] 巫善明, 徐向田, 徐伟民 , 等. 华蟾素抗鸭乙型肝炎病毒实验研究[J]. 中华传染病杂志, 1995,13(1):25-26
[5] 徐向田, 荆培棠, 李永华 , 等. 华蟾素治疗慢性乙型肝炎病毒携带者临床研究[J]. 中国中西医结合杂志, 1993,13(8):473-475
[6] 赵兴梅, 陈晓明, 杨祖贻 , 等. 华蟾素注射液对人IL-2水平及LAK细胞活性的影响[J]. 中药药理与临床, 1995,15(6):33-35
[1] Zhao-lan Liu, Qing Li , Yu-jie Mu , Ying Gao, Jian-ping Liu. Using nested case-control study to appraise the effectiveness of Chinese medicines in the treatment of diabetic nephropathy. Journal of Chinese Integrative Medicine, 2012, 10(9): 991-996.
[2] Jian-sheng Li, Ya Li, Su-yun Li, Yuan-yuan Wang, Li Deng, Yan-ge Tian, Su-li Jiang , Ying Wang. Long-term effects of Tiaobu Feishen therapies on systemic and local inflammation responses in rats with stable chronic obstructive pulmonary disease. Journal of Chinese Integrative Medicine, 2012, 10(9): 1039-1048.
[3] Zhang-ling Zhou, Cheng-xin Li, Yue-bo Jiang, Cong Zuo, Yun Cai, Rui Wang. Correlation between facial nerve functional evaluation and efficacy evaluation of acupuncture treatment for Bell’s palsy. Journal of Chinese Integrative Medicine, 2012, 10(9): 997-1002.
[4] Di Li, Guan-liang Wang, Meng-ya Shan, Jia-han Liu, Lin Wang, De-zeng Zhu. Effects of ursolic acid on c-Cbl-associated protein expression in 3T3-L1 adipocytes with insulin resistance. Journal of Chinese Integrative Medicine, 2012, 10(8): 886-893.
[5] Wei-hua Xu, Ze-huai Wen, Wei-xiong Liang, Qi Wang. A review of research on the development of instruments for therapeutic efficacy evaluation of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(7): 726-737.
[6] Yan Guan , Hui Zhang, Wei Zhang, Shi-bing Su . Analysis of differential gene expression profile in peripheral blood of patients with chronic hepatitis B and syndromes of dual deficiency of liver and kidney yin and accumulation of dampness heat. Journal of Chinese Integrative Medicine, 2012, 10(7): 751-756.
[7] Shui-qiu Deng, Xue-nong Ouyang, Zong-yang Yu, Xi-hu Dai, Xi Chen, Fang-zheng Fang, Wen-wu Wang, Zhi-zhen Liu. Influence of Chinese herbal medicine Feitai Capsule on completion or delay of chemotherapy in patients with stage ⅢB/Ⅳ non-small-cell lung cancer: a Randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 635-640.
[8] Ming-xing Zhao, Zhen-hua Dong, Zhong-hai Yu, Shi-yuan Xiao, Ya-ming Li . Effects of Ginkgo biloba extract in improving episodic memory of patients with mild cognitive impairment: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 628-634.
[9] Ju-yong Wang, Jing Guo, Chang-sheng Dong, Zhan Zheng, Qing Wang. Effects of Feiyanning Decoction, a compound traditional Chinese medicine, on iNOS and COX-2 expressions induced by tumor necrosis factor-α in lung adenocarcinoma cell line. Journal of Chinese Integrative Medicine, 2012, 10(6): 695-700.
[10] Jing Guo, Ju-yong Wang, Zhan Zheng, Qing Wang, Chang-sheng Dong . Effects of Chinese herbal medicine Feiyanning Decoction on the ratio of CD4+CD25+ regulatory T cells and expression of transcription factor Foxp3 in mice bearing Lewis lung carcinoma. Journal of Chinese Integrative Medicine, 2012, 10(5): 584-590.
[11] Zhan gheng, Ju-yong Wang, Qing Wang, Ling Xu, Zhen-ye Xu. Effects of Chinese herbal medicine Feiyanning decoction on expressions of nucleosome conformation-regulating factors H3-K56, Rtt109, Asf1 and E2F1 in Lewis-bearing mice. Journal of Chinese Integrative Medicine, 2012, 10(4): 448-453.
[12] Meenakshi Sundaram, Satyajit Patra, Gunasingham Maniarasu. Antitumor activity of ethanol extract of Gracilaria edulis (Gmelin) Silva on Ehrlich ascites carcinoma-bearing mice. Journal of Chinese Integrative Medicine, 2012, 10(4): 430-435.
[13] Li-xin Ma, Yu-yi Wang, Xin-xue Li, Jian-ping Liu . Systematic review on methodology of randomized controlled trials of post-marketing Chinese patent drugs for treatment of type 2 diabetes. Journal of Chinese Integrative Medicine, 2012, 10(3): 279-292.
[14] Mukherjee Avinaba, Sikdar Sourav, Bishayee Kausik, Paul Avijit, Ghosh Samrat, Boujedaini Naoual, Rahman Khuda-Bukhsh Anisur. Ethanolic extract of Thuja occidentalis blocks proliferation of A549 cells and induces apoptosis in vitro. Journal of Chinese Integrative Medicine, 2012, 10(12): 1451-1459.
[15] Lopes-Rocha Ricardo Barroso Poliana Ribeiro Santos Alexandre Soares Lima Nadia Lages Ferreira Fernanda Oliveiraa Verli Flaviana Dornela . Effects of propolis on lingual mucosa response of hamsters submitted to experimental carcinogenesis. Journal of Chinese Integrative Medicine, 2012, 10(12): 1443-1450.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[2] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[3] Xi Lin, Jian-ping Liu. Herbal medicines for viral myocarditis. Journal of Chinese Integrative Medicine, 2008, 6(1): 76
[4] Liang-ping Hu, Hui Gao. Discrimination of errors in statistical analysis of medical papers published in the first issue of 2006 in Journal of Chinese Integrative Medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 98-106
[5] Yan-bo Zhu , Qi Wang, Cheng-yu Wu, Guo-ming Pang, Jian-xiong Zhao, Shi-lin Shen, Zhong-yuan Xia , Xue Yan . Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. Journal of Chinese Integrative Medicine, 2010, 8(11): 1023-1035
[6] Wei Xu, Meng Shi, Jian-gang Liu, Cheng-long Wang . Collagen protein expressions in ischemic myocardium of rats with acute myocardial infarction and effects of qi-tonifying, yin-tonifying and blood-activating herbs and detoxifying and blood-activating herbs. Journal of Chinese Integrative Medicine, 2010, 8(11): 1041-1047
[7] Tao Wang , Feng Qin. Effects of Chinese herbal medicine Xiaoyao Powder on monoamine neurotransmitters in hippocampus of rats with postpartum depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1075-1079
[8] Ying Xu , Chang-chun Zeng , Xiu-yu Cai , Rong-ping Guo , Guang Nie , Ying Jin. Chromaticity and optical spectrum colorimetry of the tongue color in different syndromes of primary hepatic carcinoma. Journal of Chinese Integrative Medicine, 2012, 10(11): 1263-1271
[9] Xiang-ying Mao , Qin Bian , Zi-yin Shen. Analysis of the osteogenetic effects exerted on mesenchymal stem cell strain C3H10T1/2 by icariin via MAPK signaling pathway in vitro. Journal of Chinese Integrative Medicine, 2012, 10(11): 1272-1278
[10] Samadder Asmita, Das Jayeeta, Das Sreemanti, Biswas Raktim, Rahman Khuda-Bukhsh Anisur. Ameliorative potentials of Syzygium jambolanum extract against arsenic-induced stress in L6 cells in vitro. Journal of Chinese Integrative Medicine, 2012, 10(11): 1293-1302
[an error occurred while processing this directive]